Maria Reckova
Bratislava, BL, Slovakia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 21, 2024
The beneficial effect of probiotics in the prevention of irinotecan-induced diarrhea in colorectal cancer patients with colostomy: a pooled analysis of two probiotic trials (Probio-SK-003 and Probio-SK-005) led by Slovak Cooperative Oncology Group.
Journal: Frontiers in oncology
Published: May 26, 2024
Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients.
Journal: Frontiers in oncology
Published: February 17, 2023
Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial.
Journal: Investigational new drugs
Published: April 29, 2022
Cost-effectiveness of colorectal cancer screening in Slovakia.
Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
Published: November 18, 2021
An ongoing evolution of cardio-oncology with the rapid development of modern immunotherapy.
Journal: International journal of cardiology
Published: October 19, 2021
Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial.
Journal: European urology open science
Published: September 09, 2021
Challenges and solutions in management of cardiotoxicity induced by checkpoint inhibitors.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: October 28, 2020
Phase II study of avelumab in multiple relapsed/refractory germ cell cancer.
Journal: Investigational new drugs
Published: May 08, 2019
Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 11, 2017
Last Updated: 09/26/2026